{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T23:37:49Z","timestamp":1792798669796,"version":"4.5.0"},"reference-count":213,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:00:00Z","timestamp":1771200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:00:00Z","timestamp":1771200000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["ICMR (No.3\/1\/2(10)\/CD\/2022-NCD-II)"],"award-info":[{"award-number":["ICMR (No.3\/1\/2(10)\/CD\/2022-NCD-II)"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["ICMR (No.3\/1\/2(10)\/CD\/2022-NCD-II)"],"award-info":[{"award-number":["ICMR (No.3\/1\/2(10)\/CD\/2022-NCD-II)"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["DST-SERB (CRG\/2018\/003780)"],"award-info":[{"award-number":["DST-SERB (CRG\/2018\/003780)"]}],"id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"DOI":"10.1007\/s12020-026-04561-3","type":"journal-article","created":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T06:48:38Z","timestamp":1771224518000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["The bidirectional relationship between diabetes mellitus and liver disease: Mechanisms, clinical implications, and management strategies"],"prefix":"10.1007","volume":"91","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-4199-7746","authenticated-orcid":false,"family":"Manshi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4625-4180","authenticated-orcid":false,"given":"Debabrata","family":"Dash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1258-5160","authenticated-orcid":false,"given":"Raj Kumar","family":"Koiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,16]]},"reference":[{"key":"4561_CR1","first-page":"1","volume":"10","author":"M Karamanou","year":"2016","unstructured":"M. Karamanou, Milestones in the history of diabetes mellitus: The main contributors. Diabetes Metab. Syndr. Clin. Res. Rev. 10, 1\u20134 (2016)","journal-title":"Diabetes Metab. Syndr. Clin. Res. Rev."},{"key":"4561_CR2","first-page":"3","volume":"10","author":"G Roglic","year":"2016","unstructured":"G. Roglic, WHO Global report on diabetes: A summary. Diabetes Metab. Syndr. Clin. Res. Rev. 10, 3\u20134 (2016)","journal-title":"Diabetes Metab. Syndr. Clin. Res. Rev."},{"key":"4561_CR3","first-page":"56","volume":"8","author":"PZ Zimmet","year":"2014","unstructured":"P.Z. Zimmet, D.J. Magliano, W.H. Herman, J.E. Shaw, Diabetes: A 21st century challenge. Diabetes Metab. Syndr. Clin. Res. Rev. 8, 56\u201364 (2014)","journal-title":"Diabetes Metab. Syndr. Clin. Res. Rev."},{"key":"4561_CR4","doi-asserted-by":"publisher","first-page":"3086167","DOI":"10.1155\/2018\/3086167","volume":"2018","author":"K Papatheodorou","year":"2018","unstructured":"K. Papatheodorou, M. Banach, E. Bekiari, M. Rizzo, M. Edmonds, Complications of diabetes 2017. J. Diabetes Res. 2018, 3086167 (2018)","journal-title":"J. Diabetes Res."},{"key":"4561_CR5","first-page":"669","volume":"15","author":"LT Marton","year":"2021","unstructured":"L.T. Marton, L.M. Pescinini-E-Salzedas, M.E.C. Camargo, S.M. Barbalho, J.F.D.S. Haber, R.V. Sinatora, C.R.P. Detregiachi, R.J.S. Girio, D.V. Buchaim, P. Cincotto Dos Santos Bueno, The effects of curcumin on diabetes mellitus: A systematic review. Diabetes Metab. Syndr. Clin. Res. Rev. 15, 669\u2013679 (2021)","journal-title":"Diabetes Metab. Syndr. Clin. Res. Rev."},{"key":"4561_CR6","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.jhep.2023.03.017","volume":"79","author":"H Devarbhavi","year":"2023","unstructured":"H. Devarbhavi, S.K. Asrani, J.P. Arab, Y.A. Nartey, E. Pose, P.S. Kamath, Global burden of liver disease: 2023 update. J. Hepatol. 79, 516\u2013537 (2023)","journal-title":"J. Hepatol."},{"key":"4561_CR7","volume":"24","author":"GBD 2019 Liver Cirrhosis Collaborators","year":"2024","unstructured":"GBD 2019 Liver Cirrhosis Collaborators, Global burden of liver cirrhosis and other chronic liver diseases, 1990\u20132019: A systematic analysis for the Global Burden of Disease Study 2019. BMC Public. Health 24, 1550 (2024)","journal-title":"BMC Public. Health"},{"key":"4561_CR8","first-page":"102489","volume":"19","author":"B Corica","year":"2025","unstructured":"B. Corica, M. Proietti, Towards a broader perspective on non-alcoholic fatty liver disease and coronary artery disease relationship: Managing metabolic risk beyond genetics. Diabetes Metab. Syndr. Clin. Res. Rev. 19, 102489 (2025)","journal-title":"Diabetes Metab. Syndr. Clin. Res. Rev."},{"key":"4561_CR9","doi-asserted-by":"publisher","first-page":"421","DOI":"10.4103\/ijem.IJEM_585_17","volume":"22","author":"M Dharmalingam","year":"2018","unstructured":"M. Dharmalingam, P.G. Yamasandhi, Nonalcoholic fatty liver disease and type 2 diabetes mellitus. Indian. J. Endocrinol. Metab. 22, 421\u2013428 (2018)","journal-title":"Indian. J. Endocrinol. Metab."},{"key":"4561_CR10","first-page":"S5","volume":"28","author":"SK Han","year":"2022","unstructured":"S.K. Han, S.K. Baik, M.Y. Kim, Non-alcoholic fatty liver disease: Definition and subtypes. Clin. Mol. Hepatol. 28, S5\u2013S16 (2022)","journal-title":"Clin. Mol. Hepatol."},{"key":"4561_CR11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0316726","volume":"20","author":"CPB Moonen","year":"2025","unstructured":"C.P.B. Moonen, E.E.H.G. Brouwers, C.J.P.A. Hoebe, N.H.T.M. Dukers-Muijrers, J. Bouchaara, I.H.M. van Loo, C.D.J. den Heijer, Reaching Syrian migrants through Dutch municipal registries for hepatitis B and C point-of-care testing. PLoS One 20, e0316726 (2025)","journal-title":"PLoS One"},{"key":"4561_CR12","first-page":"973","volume":"8","author":"KR Reddy","year":"2004","unstructured":"K.R. Reddy, CON: Most patients should not be treated. Clin. Liver Dis. 8, 973\u2013975 (2004)","journal-title":"Clin. Liver Dis."},{"key":"4561_CR13","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/S2468-1253(19)30349-8","volume":"5","author":"GBD 2017 Cirrhosis Collaborators","year":"2020","unstructured":"GBD 2017 Cirrhosis Collaborators, The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990\u20132017: A systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol. Hepatol. 5, 245\u2013266 (2020)","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"4561_CR14","first-page":"339","volume":"16","author":"SM Ganie","year":"2022","unstructured":"S.M. Ganie, M.B. Malik, T. Arif, Performance analysis and prediction of type 2 diabetes mellitus based on lifestyle data using machine learning approaches. Diabetes Metab. Syndr. 16, 339\u2013352 (2022)","journal-title":"Diabetes Metab. Syndr."},{"key":"4561_CR15","first-page":"377","volume":"16","author":"JB Cole","year":"2020","unstructured":"J.B. Cole, J.C. Florez, Genetics of diabetes mellitus and diabetes complications. Nat. Rev. Endocrinol. 16, 377\u2013390 (2020)","journal-title":"Nat. Rev. Endocrinol."},{"key":"4561_CR16","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/s41574-022-00690-7","volume":"18","author":"D Tomic","year":"2022","unstructured":"D. Tomic, J.E. Shaw, D.J. Magliano, The burden and risks of emerging complications of diabetes mellitus. Nat. Rev. Endocrinol. 18, 525\u2013539 (2022)","journal-title":"Nat. Rev. Endocrinol."},{"key":"4561_CR17","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1016\/S0140-6736(21)01374-X","volume":"398","author":"P Gin\u00e8s","year":"2021","unstructured":"P. Gin\u00e8s, A. Krag, J.G. Abraldes, E. Sol\u00e0, N. Fabrellas, P.S. Kamath, Liver cirrhosis. Lancet 398, 1359\u20131376 (2021)","journal-title":"Lancet"},{"key":"4561_CR18","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1053\/j.gastro.2020.01.052","volume":"158","author":"TG Cotter","year":"2020","unstructured":"T.G. Cotter, M. Rinella, Nonalcoholic fatty liver disease 2020: The state of the disease. Gastroenterology 158, 1851\u20131864 (2020)","journal-title":"Gastroenterology"},{"key":"4561_CR19","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.mpmed.2010.08.007","volume":"38","author":"NG Forouhi","year":"2010","unstructured":"N.G. Forouhi, N.J. Wareham, Epidemiology of diabetes. Medicine 38, 602\u2013606 (2010)","journal-title":"Medicine"},{"key":"4561_CR20","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/S2213-8587(19)30076-2","volume":"7","author":"R Taylor","year":"2019","unstructured":"R. Taylor, A. Al-Mrabeh, N. Sattar, Understanding the mechanisms of reversal of type 2 diabetes. Lancet Diabetes Endocrinol. 7, 726\u2013736 (2019)","journal-title":"Lancet Diabetes Endocrinol."},{"key":"4561_CR21","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/S0140-6736(06)68341-4","volume":"367","author":"D Daneman","year":"2006","unstructured":"D. Daneman, Type 1 diabetes. Lancet 367, 847\u2013858 (2006)","journal-title":"Lancet"},{"key":"4561_CR22","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.2337\/dc06-0087","volume":"29","author":"KK Hood","year":"2006","unstructured":"K.K. Hood, S. Huestis, A. Maher, D. Butler, L. Volkening, L.M. Laffel, Depressive symptoms in children and adolescents with type 1 diabetes. Diabetes Care 29, 1389\u20131393 (2006)","journal-title":"Diabetes Care"},{"key":"4561_CR23","doi-asserted-by":"publisher","first-page":"RP96600","DOI":"10.7554\/eLife.96600.3","volume":"13","author":"Y Jiang","year":"2025","unstructured":"Y. Jiang, P. He, K. Sheng, Y. Peng, H. Wu, S. Qian, W. Ji, X. Guo, X. Shan, The protective roles of eugenol on type 1 diabetes mellitus through NRF2-mediated oxidative stress pathway. eLife 13, RP96600 (2025)","journal-title":"eLife"},{"key":"4561_CR24","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1016\/S0140-6736(18)31320-5","volume":"391","author":"LA DiMeglio","year":"2018","unstructured":"L.A. DiMeglio, C. Evans-Molina, R.A. Oram, Type 1 diabetes. Lancet 391, 2449\u20132462 (2018)","journal-title":"Lancet"},{"key":"4561_CR25","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/j.autrev.2016.02.017","volume":"15","author":"GJ Kahaly","year":"2016","unstructured":"G.J. Kahaly, M.P. Hansen, Type 1 diabetes associated autoimmunity. Autoimmun. Rev. 15, 644\u2013648 (2016)","journal-title":"Autoimmun. Rev."},{"key":"4561_CR26","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1097\/MED.0000000000000489","volume":"26","author":"RA Oram","year":"2019","unstructured":"R.A. Oram, M.J. Redondo, New insights on the genetics of type 1 diabetes. Curr. Opin. Endocrinol. Diabetes Obes. 26, 181\u2013187 (2019)","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"key":"4561_CR27","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/sj.gene.6363875","volume":"3","author":"F Pociot","year":"2002","unstructured":"F. Pociot, M.F. McDermott, Genetics of type 1 diabetes mellitus. Genes. Immun. 3, 235\u2013249 (2002)","journal-title":"Genes. Immun."},{"key":"4561_CR28","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/s11892-011-0212-0","volume":"11","author":"PR Baker","year":"2011","unstructured":"P.R. Baker, A.K. Steck, The past, present, and future of genetic associations in type 1 diabetes. Curr. Diab Rep. 11, 445\u2013453 (2011)","journal-title":"Curr. Diab Rep."},{"key":"4561_CR29","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1136\/bmj.2.6040.846","volume":"2","author":"AG Cudworth","year":"1976","unstructured":"A.G. Cudworth, J.C. Woodrow, Genetic susceptibility in diabetes mellitus: Analysis of the HLA association. BMJ 2, 846\u2013848 (1976)","journal-title":"BMJ"},{"key":"4561_CR30","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1126\/science.abi4742","volume":"373","author":"CM Dayan","year":"2021","unstructured":"C.M. Dayan, R.E.J. Besser, R.A. Oram, W. Hagopian, M. Vatish, O. Bendor-Samuel, M.D. Snape, J.A. Todd, Preventing type 1 diabetes in childhood. Science 373, 506\u2013510 (2021)","journal-title":"Science"},{"key":"4561_CR31","doi-asserted-by":"publisher","first-page":"17016","DOI":"10.1038\/nrdp.2017.16","volume":"3","author":"A Katsarou","year":"2017","unstructured":"A. Katsarou, S. Gudbj\u00f6rnsdottir, A. Rawshani, D. Dabelea, E. Bonifacio, B.J. Anderson, L.M. Jacobsen, D.A. Schatz, \u00c5. Lernmark, Type 1 diabetes mellitus. Nat. Rev. Dis. Primers 3, 17016 (2017)","journal-title":"Nat. Rev. Dis. Primers"},{"key":"4561_CR32","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1002\/(SICI)1096-9136(199605)13:5<478::AID-DIA104>3.0.CO;2-5","volume":"13","author":"E Schvarcz","year":"1996","unstructured":"E. Schvarcz, M. Palm\u00e9r, C. Ingberg, J. \u00c5man, C. Berne, Increased prevalence of upper gastrointestinal symptoms in long-term type 1 diabetes mellitus. Diabet. Med. 13, 478\u2013481 (1996)","journal-title":"Diabet. Med."},{"key":"4561_CR33","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1097\/00005082-200201000-00003","volume":"16","author":"B Fletcher","year":"2002","unstructured":"B. Fletcher, M. Gulanick, C. Lamendola, Risk factors for type 2 diabetes mellitus. J. Cardiovasc. Nurs. 16, 17\u201323 (2002)","journal-title":"J. Cardiovasc. Nurs."},{"key":"4561_CR34","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.2337\/dc12-1805","volume":"36","author":"R Taylor","year":"2013","unstructured":"R. Taylor, Type 2 diabetes: Etiology and reversibility. Diabetes Care 36, 1047\u20131055 (2013)","journal-title":"Diabetes Care"},{"key":"4561_CR35","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/S2213-8587(23)00225-5","volume":"11","author":"S Misra","year":"2023","unstructured":"S. Misra, C. Ke, S. Srinivasan, A. Goyal, M.J. Nyirenda, J.C. Florez, K. Khunti, D.J. Magliano, A. Luk, Current insights and emerging trends in early-onset type 2 diabetes. Lancet Diabetes Endocrinol. 11, 768\u2013782 (2023)","journal-title":"Lancet Diabetes Endocrinol."},{"key":"4561_CR36","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.jpeds.2004.12.042","volume":"146","author":"O Pinhas-Hamiel","year":"2005","unstructured":"O. Pinhas-Hamiel, P. Zeitler, The global spread of type 2 diabetes mellitus in children and adolescents. J. Pediatr. 146, 693\u2013700 (2005)","journal-title":"J. Pediatr."},{"key":"4561_CR37","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.beem.2016.02.006","volume":"30","author":"E Dabrowski","year":"2016","unstructured":"E. Dabrowski, R. Kadakia, D. Zimmerman, Diabetes insipidus in infants and children. Best. Pract. Res. Clin. Endocrinol. Metab. 30, 317\u2013328 (2016)","journal-title":"Best. Pract. Res. Clin. Endocrinol. Metab."},{"key":"4561_CR38","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1159\/000336333","volume":"77","author":"N Di Iorgi","year":"2012","unstructured":"N. Di Iorgi, F. Napoli, A.E.M. Allegri, I. Olivieri, E. Bertelli, A. Gallizia, A. Rossi, M. Maghnie, Diabetes insipidus\u2014diagnosis and management. Horm. Res. Paediatr. 77, 69\u201384 (2012)","journal-title":"Horm. Res. Paediatr."},{"key":"4561_CR39","doi-asserted-by":"publisher","DOI":"10.1097\/HC9.0000000000000625","volume":"9","author":"L Dumolard","year":"2025","unstructured":"L. Dumolard, T. Gerster, F. Chuffart, T. Decaens, M.N. Hilleret, S. Larrat, P. Saas, E. Jouvin-Marche, D. Durantel, P.N. Marche, Z. Macek Jilkova, C. Aspord, HBV and HBsAg strongly reshape the phenotype, function, and metabolism of DCs according to patients\u2019 clinical stage. Hepatol. Commun. 9, e0625 (2025)","journal-title":"Hepatol. Commun."},{"key":"4561_CR40","volume-title":"StatPearls [Internet]","author":"A Sharma","year":"2024","unstructured":"A. Sharma, S. Nagalli. Chronic liver disease. StatPearls [Internet]. (StatPearls Publishing, Treasure Island (FL)), 2024)"},{"key":"4561_CR41","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1016\/j.jhep.2012.07.020","volume":"57","author":"E Sol\u00e0","year":"2012","unstructured":"E. Sol\u00e0, H. Watson, I. Graupera, F. Tur\u00f3n, R. Barreto, E. Rodr\u00edguez, M. Pavesi, V. Arroyo, M. Guevara, P. Gin\u00e8s, Factors related to quality of life in patients with cirrhosis and ascites: Relevance of serum sodium concentration and leg edema. J. Hepatol. 57, 1199\u20131206 (2012)","journal-title":"J. Hepatol."},{"key":"4561_CR42","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1128\/MMBR.64.1.51-68.2000","volume":"64","author":"C Seeger","year":"2000","unstructured":"C. Seeger, W.S. Mason, Hepatitis B virus biology. Microbiol. Mol. Biol. Rev. 64, 51\u201368 (2000)","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"4561_CR43","doi-asserted-by":"publisher","first-page":"455","DOI":"10.2147\/IDR.S487414","volume":"18","author":"Y Zhang","year":"2025","unstructured":"Y. Zhang, H. Xia, L. Fan, L. Jiang, B. Yang, F. Wang, Five-year prospective follow-up of patients with hepatitis C virus infection treated with direct-acting antiviral agents. Infect. Drug. Resist. 18, 455\u2013471 (2025)","journal-title":"Infect. Drug. Resist."},{"key":"4561_CR44","doi-asserted-by":"publisher","first-page":"102026","DOI":"10.1016\/j.toxrep.2025.102026","volume":"14","author":"D Dash","year":"2025","unstructured":"D. Dash, R.K. Rai, R.K. Koiri, Mitigating renal dysfunction in liver cirrhosis: Therapeutic role of ferrous sulphate, folic acid and its co-administration. Toxicol. Rep. 14, 102026 (2025)","journal-title":"Toxicol. Rep."},{"key":"4561_CR45","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1093\/aje\/kwn280","volume":"169","author":"B Liu","year":"2009","unstructured":"B. Liu, A. Balkwill, A. Roddam, A. Brown, V. Beral, Separate and joint effects of alcohol and smoking on the risks of cirrhosis and gallbladder disease in middle-aged women. Am. J. Epidemiol. 169, 153\u2013160 (2009)","journal-title":"Am. J. Epidemiol."},{"key":"4561_CR46","doi-asserted-by":"publisher","first-page":"100710","DOI":"10.1016\/j.prmcm.2025.100710","volume":"17","author":"D Dash","year":"2025","unstructured":"D. Dash, R.K. Koiri, Therapeutic modulation of unfolded protein response by biochemic tissue salts in alcohol- and acetaminophen-induced liver cirrhosis. Pharmacol. Res. Mod. Chin. Med. 17, 100710 (2025)","journal-title":"Pharmacol. Res. Mod. Chin. Med."},{"key":"4561_CR47","first-page":"1195","volume":"21","author":"RS Britton","year":"1995","unstructured":"R.S. Britton, K.E. Brown, Genetic hemochromatosis and Wilson\u2019s disease: Role for oxidant stress? Hepatology 21, 1195\u20131197 (1995)","journal-title":"Hepatology"},{"key":"4561_CR48","doi-asserted-by":"publisher","first-page":"280","DOI":"10.3748\/wjg.15.280","volume":"15","author":"D Garc\u00eda-Compe\u00e1n","year":"2009","unstructured":"D. Garc\u00eda-Compe\u00e1n, J. J\u00e1quez-Quintana, J.A. Gonz\u00e1lez-Gonz\u00e1lez, H.J. Maldonado-Garza, Liver cirrhosis and diabetes: Risk factors, pathophysiology, clinical implications and management. World J. Gastroenterol. 15, 280\u2013288 (2009)","journal-title":"World J. Gastroenterol."},{"key":"4561_CR49","doi-asserted-by":"publisher","first-page":"a031708","DOI":"10.1101\/cshperspect.a031708","volume":"8","author":"E Shin","year":"2018","unstructured":"E. Shin, S. Jeong, Natural history, clinical manifestations, and pathogenesis of hepatitis A. Cold Spring Harb. Perspect. Med. 8, a031708 (2018)","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"4561_CR50","doi-asserted-by":"publisher","first-page":"6385","DOI":"10.3390\/ijms21176384","volume":"21","author":"T Kanda","year":"2020","unstructured":"T. Kanda, R. Sasaki, R. Masuzaki, H. Takahashi, T. Mizutani, N. Matsumoto, K. Nirei, M. Moriyama, Co-occurrence of hepatitis A infection and chronic liver disease. Int. J. Mol. Sci. 21, 6385 (2020)","journal-title":"Int. J. Mol. Sci."},{"key":"4561_CR51","first-page":"429","volume":"86","author":"M Doulberis","year":"2023","unstructured":"M. Doulberis, A. Papaefthymiou, S. Polyzos, E. Vardaka, M. Tzitiridou-Chatzopoulou, D. Chatzopoulos, A. Koffas, V. Papadopoulos, F. Kyrailidi, J. Kountouras, Local and systemic autoimmune manifestations linked to hepatitis A infection. Acta Gastroenterol. Belg. 86, 429\u2013436 (2023)","journal-title":"Acta Gastroenterol. Belg."},{"key":"4561_CR52","first-page":"710","volume":"16","author":"T Kanda","year":"2022","unstructured":"T. Kanda, R. Sasaki-Tanaka, S. Nakamoto, Hepatitis A virus infection and molecular research. Diabetes Metab. Syndr. Clin. Res. Rev. 16, 710\u2013715 (2022)","journal-title":"Diabetes Metab. Syndr. Clin. Res. Rev."},{"key":"4561_CR53","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1002\/hep.27406","volume":"60","author":"FS Wang","year":"2014","unstructured":"F.S. Wang, J.G. Fan, Z. Zhang, B. Gao, H.Y. Wang, The global burden of liver disease: The major impact of China. Hepatology 60, 2099\u20132108 (2014)","journal-title":"Hepatology"},{"key":"4561_CR54","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.1002\/hep.22881","volume":"49","author":"TJ Liang","year":"2009","unstructured":"T.J. Liang, Hepatitis B: The virus and disease. Hepatology 49, S13\u2013S21 (2009)","journal-title":"Hepatology"},{"key":"4561_CR55","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3390\/pathogens14010011","volume":"14","author":"N Kerkar","year":"2024","unstructured":"N. Kerkar, K. Hartjes, Hepatitis C virus\u2014pediatric and adult perspectives in the current decade. Pathogens 14, 11 (2024)","journal-title":"Pathogens"},{"key":"4561_CR56","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/S1473-3099(05)70216-4","volume":"5","author":"CW Shepard","year":"2005","unstructured":"C.W. Shepard, L. Finelli, M.J. Alter, Global epidemiology of hepatitis C virus infection. Lancet Infect. Dis. 5, 558\u2013567 (2005)","journal-title":"Lancet Infect. Dis."},{"key":"4561_CR57","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.gtc.2020.01.001","volume":"49","author":"H Razavi","year":"2020","unstructured":"H. Razavi, Global epidemiology of viral hepatitis. Gastroenterol. Clin. North. Am. 49, 179\u2013189 (2020)","journal-title":"Gastroenterol. Clin. North. Am."},{"key":"4561_CR58","doi-asserted-by":"publisher","first-page":"5543","DOI":"10.3748\/wjg.v26.i37.5543","volume":"26","author":"A Aslan","year":"2020","unstructured":"A. Aslan, H. Balaban, Hepatitis E virus: Epidemiology, diagnosis, clinical manifestations, and treatment. World J. Gastroenterol. 26, 5543\u20135560 (2020)","journal-title":"World J. Gastroenterol."},{"key":"4561_CR59","doi-asserted-by":"publisher","first-page":"2989","DOI":"10.3390\/jcm9020331","volume":"9","author":"S Lhomme","year":"2020","unstructured":"S. Lhomme, O. Marion, F. Abravanel, J. Izopet, N. Kamar, Clinical manifestations, pathogenesis and treatment of hepatitis E virus infections. J. Clin. Med. 9, 2989 (2020)","journal-title":"J. Clin. Med."},{"key":"4561_CR60","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1111\/apt.14109","volume":"46","author":"M Donnelly","year":"2017","unstructured":"M. Donnelly, L. Scobie, C. Crossan, H. Dalton, P. Hayes, K. Simpson, Hepatitis E: A concise review of virology, epidemiology, clinical presentation, and therapy. Aliment. Pharmacol. Ther. 46, 126\u2013141 (2017)","journal-title":"Aliment. Pharmacol. Ther."},{"key":"4561_CR61","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1016\/j.cmi.2020.03.039","volume":"26","author":"G Webb","year":"2020","unstructured":"G. Webb, H. Dalton, Hepatitis E: An expanding epidemic with a range of complications. Clin. Microbiol. Infect. 26, 1614\u20131621 (2020)","journal-title":"Clin. Microbiol. Infect."},{"key":"4561_CR62","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1002\/hep.510290235","volume":"29","author":"AL Mason","year":"1999","unstructured":"A.L. Mason, J.Y. Lau, N. Hoang, K. Qian, G. Alexander, L. Xu, L. Guo, S. Jacob, F. Regenstein, R. Zimmerman, J. Everhart, C. Wasserfall, N. Maclaren, R.P. Perrillo, Association of diabetes mellitus and chronic hepatitis C virus infection. Hepatology 29, 1366\u20131371 (1999)","journal-title":"Hepatology"},{"key":"4561_CR63","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1002\/hep.510300225","volume":"30","author":"\u0130 Bal\u0131k","year":"1999","unstructured":"\u0130. Bal\u0131k, N. Y\u0131lmaz, N. Turk\u00e7apar, H. Ya\u015fa, Association of diabetes mellitus and chronic hepatitis C virus infection. Hepatology 30, 145\u2013149 (1999)","journal-title":"Hepatology"},{"key":"4561_CR64","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1007\/s11892-004-0023-7","volume":"4","author":"G Bahtiyar","year":"2004","unstructured":"G. Bahtiyar, J. Shin, A. Aytaman, J.R. Sowers, S.I. McFarlane, Association of diabetes and hepatitis C infection: Epidemiologic evidence and pathophysiologic insights. Curr. Diab Rep. 4, 194\u2013198 (2004)","journal-title":"Curr. Diab Rep."},{"key":"4561_CR65","doi-asserted-by":"publisher","first-page":"101162","DOI":"10.1016\/j.aohep.2023.101162","volume":"29","author":"H Hern\u00e1ndez-\u00c9vole","year":"2024","unstructured":"H. Hern\u00e1ndez-\u00c9vole, N. Jim\u00e9nez-Esquivel, E. Pose, R. Bataller, Alcohol-associated liver disease: Epidemiology and management. Ann. Hepatol. 29, 101162 (2024)","journal-title":"Ann. Hepatol."},{"key":"4561_CR66","doi-asserted-by":"publisher","DOI":"10.1172\/JCI176345","volume":"134","author":"B Mackowiak","year":"2024","unstructured":"B. Mackowiak, Y. Fu, L. Maccioni, B. Gao, Alcohol-associated liver disease. J. Clin. Invest. 134, e157596 (2024)","journal-title":"J. Clin. Invest."},{"key":"4561_CR67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/hep.30866","volume":"71","author":"DW Crabb","year":"2020","unstructured":"D.W. Crabb, G.Y. Im, G. Szabo, J. Mellinger, M.R. Lucey, Diagnosis and treatment of alcohol-associated liver diseases: 2019 practice guidance from the American Association for the Study of Liver Diseases. Hepatology 71, 1\u201317 (2020)","journal-title":"Hepatology"},{"key":"4561_CR68","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41572-018-0014-7","volume":"4","author":"HK Seitz","year":"2018","unstructured":"H.K. Seitz, R. Bataller, H. Cortez-Pinto, B. Gao, A. Gual, C. Lackner, P. Mathurin, S. Mueller, G. Szabo, H. Tsukamoto, Alcoholic liver disease. Nat. Rev. Dis. Primers 4, 16 (2018)","journal-title":"Nat. Rev. Dis. Primers"},{"key":"4561_CR69","doi-asserted-by":"crossref","first-page":"7030","DOI":"10.3390\/ijms22137030","volume":"22","author":"S Liu","year":"2021","unstructured":"S. Liu, I. Tsai, Y. Hsu, Alcohol-related liver disease: Basic mechanisms and clinical perspectives. Int. J. Mol. Sci. 22, 7030 (2021)","journal-title":"Int. J. Mol. Sci."},{"key":"4561_CR70","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1038\/s41395-018-0182-9","volume":"113","author":"N Hussen","year":"2018","unstructured":"N. Hussen, L. Zhu, E. Tetangco, S. Ellison, Hepatoptosis in a patient with alcoholic hepatitis. Am. J. Gastroenterol. 113, 1581\u20131583 (2018)","journal-title":"Am. J. Gastroenterol."},{"key":"4561_CR71","doi-asserted-by":"publisher","first-page":"759","DOI":"10.12688\/f1000research.14841.1","volume":"7","author":"R Weiskirchen","year":"2018","unstructured":"R. Weiskirchen, S. Weiskirchen, F. Tacke, Recent advances in understanding liver fibrosis: Bridging basic science and individualized treatment concepts. F1000Res 7, 759 (2018)","journal-title":"F1000Res"},{"key":"4561_CR72","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1111\/jgh.16282","volume":"38","author":"M Chen","year":"2023","unstructured":"M. Chen, W. Zhong, W. Xu, Alcohol and the mechanisms of liver disease. J. Gastroenterol. Hepatol. 38, 1233\u20131240 (2023)","journal-title":"J. Gastroenterol. Hepatol."},{"key":"4561_CR73","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1146\/annurev-pathmechdis-031521-030435","volume":"18","author":"X Wu","year":"2022","unstructured":"X. Wu, X. Fan, T. Miyata, A. Kim, C. Ross, S. Ray, E. Huang, M. Taiwo, R. Arya, J. Wu, L. Nagy, Recent advances in understanding of pathogenesis of alcohol-associated liver disease. Annu. Rev. Pathol. 18, 411\u2013438 (2022)","journal-title":"Annu. Rev. Pathol."},{"key":"4561_CR74","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.numecd.2010.05.001","volume":"20","author":"A Pietraszek","year":"2010","unstructured":"A. Pietraszek, S. Gregersen, K. Hermansen, Alcohol and type 2 diabetes: A review. Nutr. Metab. Cardiovasc. Dis. 20, 366\u2013375 (2010)","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"4561_CR75","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1007\/s00125-004-1526-0","volume":"47","author":"I Shai","year":"2004","unstructured":"I. Shai, M.J. Stampfer, M.B. Schulze, F.B. Hu, N. Rifai, E.B. Rimm, Moderate alcohol intake and markers of inflammation and endothelial dysfunction among diabetic men. Diabetologia 47, 1760\u20131767 (2004)","journal-title":"Diabetologia"},{"key":"4561_CR76","first-page":"lnae030","volume":"18","author":"L Sun","year":"2024","unstructured":"L. Sun, Z. Yue, L. Wang, Research on the function of epigenetic regulation in the inflammation of non-alcoholic fatty liver disease. Diabetes Metab. Syndr. Clin. Res. Rev. 18, lnae030 (2024)","journal-title":"Diabetes Metab. Syndr. Clin. Res. Rev."},{"key":"4561_CR77","volume":"19","author":"P Le","year":"2025","unstructured":"P. Le, M. Tatar, S. Dasarathy, N. Alkhouri, W.H. Herman, G.B. Taksler, A. Deshpande, W. Ye, O.A. Adekunle, A. McCullough, M.B. Rothberg, Estimated burden of metabolic dysfunction-associated steatotic liver disease in US adults, 2020 to 2050. Diabetes Metab. Syndr. Clin. Res. Rev. 19, e2454707 (2025)","journal-title":"Diabetes Metab. Syndr. Clin. Res. Rev."},{"key":"4561_CR78","doi-asserted-by":"publisher","first-page":"9674","DOI":"10.3748\/wjg.v22.i44.9674","volume":"22","author":"A Lonardo","year":"2016","unstructured":"A. Lonardo, S. Ballestri, G. Guaraldi, F. Nascimbeni, D. Romagnoli, S. Zona, G. Targher, Fatty liver is associated with an increased risk of diabetes and cardiovascular disease: Evidence from three different disease models: NAFLD, HCV and HIV. World J. Gastroenterol. 22, 9674\u20139683 (2016)","journal-title":"World J. Gastroenterol."},{"key":"4561_CR79","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.hepres.2005.09.012","volume":"33","author":"N Agarwal","year":"2005","unstructured":"N. Agarwal, B.C. Sharma, Insulin resistance and clinical aspects of non-alcoholic steatohepatitis (NASH). Hepatol. Res. 33, 92\u201396 (2005)","journal-title":"Hepatol. Res."},{"key":"4561_CR80","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1097\/00042737-200508000-00008","volume":"17","author":"M Machado","year":"2005","unstructured":"M. Machado, H. Cortez-Pinto, Non-alcoholic fatty liver disease and insulin resistance. Eur. J. Gastroenterol. Hepatol. 17, 823\u2013826 (2005)","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"4561_CR81","first-page":"101174","volume":"42","author":"H Naik","year":"2024","unstructured":"H. Naik, M. Brown, S. Meninger, S. Lombardelli, Patient experience with acute hepatic porphyria before and after long-term givosiran treatment in a qualitative interview study. Mol. Genet. Metab. Rep. 42, 101174 (2024)","journal-title":"Mol. Genet. Metab. Rep."},{"key":"4561_CR82","first-page":"1","volume":"47","author":"E Pischik","year":"2015","unstructured":"E. Pischik, R. Kauppinen, An update of clinical management of acute intermittent porphyria. Ann. Med. 47, 1\u201310 (2015)","journal-title":"Ann. Med."},{"key":"4561_CR83","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/bjh.14459","volume":"176","author":"P Stein","year":"2017","unstructured":"P. Stein, M. Badminton, D. Rees, Update review of the acute porphyrias. Br. J. Haematol. 176, 5\u201317 (2017)","journal-title":"Br. J. Haematol."},{"key":"4561_CR84","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1002\/hep4.1297","volume":"3","author":"B Wang","year":"2018","unstructured":"B. Wang, S. Rudnick, B. Cengia, H. Bonkovsky, Acute hepatic porphyrias: Review and recent progress. Hepatol. Commun. 3, 193\u2013206 (2018)","journal-title":"Hepatol. Commun."},{"key":"4561_CR85","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.ymgme.2019.03.002","volume":"128","author":"H Bonkovsky","year":"2019","unstructured":"H. Bonkovsky, N. Dixon, S. Rudnick, Pathogenesis and clinical features of the acute hepatic porphyrias (AHPs). Mol. Genet. Metab. 128, 213\u2013227 (2019)","journal-title":"Mol. Genet. Metab."},{"key":"4561_CR86","doi-asserted-by":"publisher","first-page":"297","DOI":"10.3390\/biomedicines9030255","volume":"9","author":"I Solares","year":"2021","unstructured":"I. Solares, L. Izquierdo-S\u00e1nchez, M. Morales-Conejo, D. Jeric\u00f3, F. Castelb\u00f3n, K. C\u00f3rdoba, A. Sampedro, C. Lumbreras, M. Moreno-Aliaga, E. De Salamanca, P. Berraondo, A. Fontanellas, High prevalence of insulin resistance in asymptomatic patients with acute intermittent porphyria and liver-targeted insulin as a novel therapeutic approach. Biomedicines 9, 297 (2021)","journal-title":"Biomedicines"},{"key":"4561_CR87","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.3390\/ijms24010051","volume":"24","author":"I Solares","year":"2022","unstructured":"I. Solares, D. Jeric\u00f3, K. C\u00f3rdoba, M. Morales-Conejo, J. Ena, E. De Salamanca, A. Fontanellas, Understanding carbohydrate metabolism and insulin resistance in acute intermittent porphyria. Int. J. Mol. Sci. 24, 2230 (2022)","journal-title":"Int. J. Mol. Sci."},{"key":"4561_CR88","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1136\/bmj.295.6608.1238","volume":"295","author":"A Corder","year":"1987","unstructured":"A. Corder, Steroids, non-steroidal anti-inflammatory drugs, and serious septic complications of diverticular disease. Br. Med. J. 295, 1238 (1987)","journal-title":"Br. Med. J."},{"key":"4561_CR89","doi-asserted-by":"publisher","first-page":"797","DOI":"10.2337\/diacare.25.4.797","volume":"25","author":"F Lithner","year":"2002","unstructured":"F. Lithner, Beneficial effect of diabetes on acute intermittent porphyria. Diabetes Care 25, 797\u2013798 (2002)","journal-title":"Diabetes Care"},{"key":"4561_CR90","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1111\/j.1464-5491.1991.tb01626.x","volume":"8","author":"DK Andersson","year":"1991","unstructured":"D.K. Andersson, K. Sv\u00e4rdsudd, G. Tibblin, Prevalence and incidence of diabetes in a Swedish community 1972\u20131987. Diabet. Med. 8, 428\u2013434 (1991)","journal-title":"Diabet. Med."},{"key":"4561_CR91","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"H. Sung, J. Ferlay, R.L. Siegel, M. Laversanne, I. Soerjomataram, A. Jemal, F. Bray, Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71, 209\u2013249 (2021)","journal-title":"CA Cancer J. Clin."},{"key":"4561_CR92","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.jhep.2018.03.019","volume":"69","author":"European Association for the Study of the Liver","year":"2018","unstructured":"European Association for the Study of the Liver, EASL clinical practice guidelines: Management of hepatocellular carcinoma. J. Hepatol. 69, 182\u2013236 (2018)","journal-title":"J. Hepatol."},{"key":"4561_CR93","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","volume":"64","author":"ZM Younossi","year":"2016","unstructured":"Z.M. Younossi, A.B. Koenig, D. Abdelatif, Y. Fazel, L. Henry, M. Wymer, Global epidemiology of nonalcoholic fatty liver disease\u2014Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology 64, 73\u201384 (2016)","journal-title":"Hepatology"},{"key":"4561_CR94","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1002\/hep.30911","volume":"71","author":"T Sandahl","year":"2020","unstructured":"T. Sandahl, T. Laursen, D. Munk, H. Vilstrup, K. Weiss, P. Ott, The prevalence of Wilson\u2019s disease: An update. Hepatology 71, 1920\u20131932 (2020)","journal-title":"Hepatology"},{"key":"4561_CR95","doi-asserted-by":"publisher","first-page":"2798","DOI":"10.3390\/ijms25094753","volume":"25","author":"R Teschke","year":"2024","unstructured":"R. Teschke, A. Eickhoff, Wilson disease: Copper-mediated cuproptosis, iron-related ferroptosis, and clinical highlights, with comprehensive and critical analysis update. Int. J. Mol. Sci. 25, 2798 (2024)","journal-title":"Int. J. Mol. Sci."},{"key":"4561_CR96","doi-asserted-by":"crossref","unstructured":"C.A. Zeid, L. Yi, S.G. Kaler, Copper metabolism and the liver. In: The Liver: Biology and Pathobiology, pp. 207\u2013214 (2020).","DOI":"10.1002\/9781119436812.ch18"},{"key":"4561_CR97","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/BF00716470","volume":"146","author":"T Saito","year":"1987","unstructured":"T. Saito, Presenting symptoms and natural history of Wilson disease. Eur. J. Pediatr. 146, 261\u2013265 (1987)","journal-title":"Eur. J. Pediatr."},{"key":"4561_CR98","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-020-70976-1","volume":"10","author":"E Choe","year":"2020","unstructured":"E. Choe, J. Choi, M. Kang, Y. Lee, H. Jeon, B. Park, S. Won, Y. Cho, J. Seo, C. Lee, J. Chung, A population-based epidemiology of Wilson\u2019s disease in South Korea between 2010 and 2016. Sci. Rep. 10, 1\u20138 (2020)","journal-title":"Sci. Rep."},{"key":"4561_CR99","doi-asserted-by":"crossref","unstructured":"J. Jankovic, M. Hallett, M.S. Okun, C.L. Comella, S. Fahn: Wilson disease. In: Principles and Practice of Movement Disorders, 3rd edn. Elsevier, Amsterdam (2021)","DOI":"10.1016\/B978-0-323-31071-0.00022-6"},{"key":"4561_CR100","doi-asserted-by":"publisher","first-page":"202","DOI":"10.3390\/biomedicines9091100","volume":"9","author":"A S\u00e1nchez-Monteagudo","year":"2021","unstructured":"A. S\u00e1nchez-Monteagudo, E. Ripoll\u00e9s, M. Berenguer, C. Espin\u00f3s, Wilson\u2019s disease: Facing the challenge of diagnosing a rare disease. Biomedicines 9, 202 (2021)","journal-title":"Biomedicines"},{"key":"4561_CR101","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1055\/s-2000-9389","volume":"20","author":"G Loudianos","year":"2000","unstructured":"G. Loudianos, J.D. Gitlin, Wilson\u2019s disease. Semin. Liver Dis. 20, 353\u2013364 (2000)","journal-title":"Semin. Liver Dis."},{"key":"4561_CR102","first-page":"1731","volume":"15","author":"S Zhong","year":"2021","unstructured":"S. Zhong, Z. Deng, L. Jiang, J. Zeng, T. Yu, Wilson\u2019s disease with hepatogenous diabetes: A case report. Diabetes Metab. Syndr. Clin. Res. Rev. 15, 1731\u20131734 (2021)","journal-title":"Diabetes Metab. Syndr. Clin. Res. Rev."},{"key":"4561_CR103","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.2337\/dc19-2033","volume":"43","author":"J Li","year":"2020","unstructured":"J. Li, Y. Jiang, T. Xu, Y. Zhang, J. Xue, X. Gao, X. Yang, X. Wang, X. Jia, W. Cheng, S. Jin, Wilson disease with novel compound heterozygote mutations in the ATP7B gene presenting with severe diabetes. Diabetes Care 43, 1363\u20131365 (2020)","journal-title":"Diabetes Care"},{"key":"4561_CR104","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1007\/s40265-019-01126-9","volume":"79","author":"P Manka","year":"2019","unstructured":"P. Manka, A. Zeller, W.K. Syn, Fibrosis in chronic liver disease: An update on diagnostic and treatment modalities. Drugs 79, 903\u2013927 (2019)","journal-title":"Drugs"},{"key":"4561_CR105","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1002\/hep.27332","volume":"61","author":"E Seki","year":"2015","unstructured":"E. Seki, R.F. Schwabe, Hepatic inflammation and fibrosis: Functional links and key pathways. Hepatology 61, 1066\u20131075 (2015)","journal-title":"Hepatology"},{"key":"4561_CR106","doi-asserted-by":"publisher","first-page":"30","DOI":"10.21037\/dmr-21-87","volume":"5","author":"KL Poulsen","year":"2022","unstructured":"K.L. Poulsen, C.K. Cajigas-Du Ross, J.K. Chaney, L.E. Nagy, Role of the chemokine system in liver fibrosis: A narrative review. Dig. Med. Res. 5, 30 (2022)","journal-title":"Dig. Med. Res."},{"key":"4561_CR107","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1007\/s00204-015-1543-4","volume":"90","author":"S Yanguas","year":"2016","unstructured":"S. Yanguas, B. Cogliati, J. Willebrords, M. Maes, I. Colle, B. Van Den Bossche, C. Oliveira, W. Andraus, V.A. Alves, I.A. Leclercq, M. Vinken, Experimental models of liver fibrosis. Arch. Toxicol. 90, 1025\u20131048 (2016)","journal-title":"Arch. Toxicol."},{"key":"4561_CR108","doi-asserted-by":"publisher","first-page":"607","DOI":"10.3389\/fendo.2024.1302611","volume":"15","author":"G Huo","year":"2024","unstructured":"G. Huo, Y. Gao, Type 1 diabetes and combined acute and chronic complications are associated with risk of progression of liver fibrosis: A Mendelian randomization study. Front. Endocrinol. 15, 607 (2024)","journal-title":"Front. Endocrinol."},{"key":"4561_CR109","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2024-089369","volume":"15","author":"P Singh","year":"2025","unstructured":"P. Singh, C. Millson, C. Huang, R.J. Driver, Identifying haemochromatosis patients with C282Y homozygosity from inpatient electronic patient records in England using a novel algorithm: A retrospective observational study. BMJ Open. 15, e089369 (2025)","journal-title":"BMJ Open."},{"key":"4561_CR110","volume-title":"Hemochromatosis. In: StatPearls [Internet","author":"JL Porter","year":"2024","unstructured":"J.L. Porter, P. Rawla. Hemochromatosis. In: StatPearls [Internet. (StatPearls Publishing, Treasure Island (FL)), 2024)"},{"key":"4561_CR111","unstructured":"A. Piperno, F. Bertola, A. Bentivegna, M.P. Adam, H.H. Ardinger, R.A. Pagon, S.E. Wallace, L.J.H. Bean, G. Mirzaa, A. Amemiya (eds.), Juvenile hemochromatosis. In: GeneReviews\u00ae. University of Washington, Seattle (2005)."},{"key":"4561_CR112","doi-asserted-by":"publisher","first-page":"172","DOI":"10.5005\/jp-journals-10018-1444","volume":"14","author":"AS Gani","year":"2024","unstructured":"A.S. Gani, A. Al Mahmood, A.S. Alam, M. Rahman, R. Alam, T. Mahmud, Higher incidence of diabetes in asymptomatic healthy fatty liver patients of Bangladesh: Prompt intervention can avert complications. Euroasian J. Hepato-Gastroenterol 14, 172\u2013175 (2024)","journal-title":"Euroasian J. Hepato-Gastroenterol"},{"key":"4561_CR113","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.3390\/ijms24021703","volume":"24","author":"R Nevola","year":"2023","unstructured":"R. Nevola, R. Epifani, S. Imbriani, G. Tortorella, C. Aprea, R. Galiero, L. Rinaldi, R. Marfella, F.C. Sasso, GLP-1 receptor agonists in non-alcoholic fatty liver disease: Current evidence and future perspectives. Int. J. Mol. Sci. 24, 1703 (2023)","journal-title":"Int. J. Mol. Sci."},{"key":"4561_CR114","doi-asserted-by":"publisher","first-page":"93","DOI":"10.21037\/atm.2019.12.110","volume":"8","author":"J Fang","year":"2020","unstructured":"J. Fang, L. Pan, Q.X. Gu, S. Juengpanich, J.H. Zheng, C.H. Tong, Z.Y. Wang, J.J. Nan, Y.F. Wang, Scientometric analysis of mTOR signaling pathway in liver disease. Ann. Transl. Med. 8, 93 (2020)","journal-title":"Ann. Transl. Med."},{"key":"4561_CR115","first-page":"1827","volume":"20","author":"D Di Scienze Cliniche e di Comunit\u00e0","year":"2023","unstructured":"D. Di Scienze Cliniche e di Comunit\u00e0, A.M. Mediche, Dietary interventions targeting glucose metabolism and hyperinsulinemia: A new translational perspective for the management of acute intermittent porphyria. Diabetes Metab. Syndr. Clin. Res. Rev. 20, 1827\u20131834 (2023)","journal-title":"Diabetes Metab. Syndr. Clin. Res. Rev."},{"key":"4561_CR116","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1042\/BJ20111005","volume":"442","author":"L Oliveri","year":"2012","unstructured":"L. Oliveri, C. Davio, A. Batlle, E. Gerez, ALAS1 gene expression is down-regulated by Akt-mediated phosphorylation and nuclear exclusion of FOXO1 by vanadate in diabetic mice. Biochem. J. 442, 303\u2013310 (2012)","journal-title":"Biochem. J."},{"key":"4561_CR117","doi-asserted-by":"crossref","first-page":"10153","DOI":"10.1073\/pnas.0504023102","volume":"102","author":"C Handschin","year":"2005","unstructured":"C. Handschin, J. Lin, J. Rhee, A.K. Peyer, S. Chin, P.H. Wu, U.A. Meyer, Nutritional regulation of hepatic heme biosynthesis and porphyria through PGC-1\u03b1. Proc. Natl Acad. Sci. USA 102, 10153\u201310158 (2005)","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"4561_CR118","first-page":"1","volume":"148","author":"Y Lin","year":"2019","unstructured":"Y. Lin, Z. Lin, Y. Xu, L.C. Milbauer, N. He, D.S. Edgell, J.D. Phillips, Oxidative stress and insulin resistance in porphyria. Diabetes Res. Clin. Pract. 148, 1\u201311 (2019)","journal-title":"Diabetes Res. Clin. Pract."},{"key":"4561_CR119","doi-asserted-by":"crossref","first-page":"101475","DOI":"10.1016\/j.redox.2020.101485","volume":"32","author":"B Chen","year":"2020","unstructured":"B. Chen, C. Solis-Villa, J. Hakenberg, W. Qiao, R.R. Srinivasan, M. Yasuda, Acute intermittent porphyria: Predicted pathogenicity of HMBS variants indicates extremely low penetrance of the autosomal dominant disease. Redox Biol. 32, 101475 (2020)","journal-title":"Redox Biol."},{"key":"4561_CR120","first-page":"1153","volume":"60","author":"C Meyer","year":"2017","unstructured":"C. Meyer, B.P. McGrath, H.J. Teede, Insulin resistance, the metabolic syndrome, and diabetes. Diabetologia 60, 1153\u20131162 (2017)","journal-title":"Diabetologia"},{"key":"4561_CR121","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1007\/s00384-008-0555-4","volume":"23","author":"K Piekarek","year":"2008","unstructured":"K. Piekarek, L.A. Israelsson, Perforated colonic diverticular disease: the importance of NSAIDs, opioids, corticosteroids, and calcium channel blockers. Int. J. Colorectal Dis. 23, 1193\u20131197 (2008)","journal-title":"Int. J. Colorectal Dis."},{"key":"4561_CR122","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1111\/j.1365-2133.2011.10401.x","volume":"165","author":"C Mu\u00f1oz-Santos","year":"2011","unstructured":"C. Mu\u00f1oz-Santos, A. Guilabert, N. Moreno, M. Gimenez, E. Darwich, J. To-Figueras, C. Herrero, The association between porphyria cutanea tarda and diabetes mellitus: analysis of a long-term follow-up cohort. Br. J. Dermatol. 165, 486\u2013491 (2011)","journal-title":"Br. J. Dermatol."},{"key":"4561_CR123","doi-asserted-by":"publisher","first-page":"975","DOI":"10.3390\/life12081270","volume":"12","author":"E Storjord","year":"2022","unstructured":"E. Storjord, S. Airila-M\u00e5nsson, K. Karlsen, M. Madsen, J. Dahl, A. Landsem, H. Fure, J. Ludviksen, J. Fj\u00f8se, A. Dickey, B. Karlsen, W. Nielsen, T. Mollnes, O. Brekke, Dental and periodontal health in acute intermittent porphyria. Life 12, 975 (2022)","journal-title":"Life"},{"key":"4561_CR124","first-page":"125","volume":"22","author":"N Toma","year":"2015","unstructured":"N. Toma, M. Stancu, O. Savu, Late acute intermittent porphyria attack in a patient with type 2 diabetes. Rom. J. Diabetes Nutr. Metab. Dis. 22, 125\u2013131 (2015)","journal-title":"Rom. J. Diabetes Nutr. Metab. Dis."},{"key":"4561_CR125","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1001\/archinte.1949.00230060122009","volume":"84","author":"K Sterling","year":"1949","unstructured":"K. Sterling, M. Silver, H. Ricketts, Development of porphyria in diabetes mellitus: Report of three cases. Arch. Intern. Med. 84, 965\u2013975 (1949)","journal-title":"Arch. Intern. Med."},{"key":"4561_CR126","first-page":"262","volume":"27","author":"HB El-Serag","year":"2004","unstructured":"H.B. El-Serag, H. Hampel, F. Javadi, The association between diabetes and hepatocellular carcinoma: A systematic review of epidemiologic evidence. Diabetes Care 27, 262\u2013267 (2004)","journal-title":"Diabetes Care"},{"key":"4561_CR127","first-page":"570","volume":"57","author":"DL White","year":"2013","unstructured":"D.L. White, V. Ratziu, H.B. El-Serag, Hepatitis C infection and risk of diabetes: A systematic review and meta-analysis. Hepatology 57, 570\u2013579 (2013)","journal-title":"Hepatology"},{"key":"4561_CR128","doi-asserted-by":"publisher","first-page":"3280","DOI":"10.3390\/biomedicines11123280","volume":"11","author":"N Li","year":"2023","unstructured":"N. Li, X. Li, Y. Ding, X. Liu, K. Diggle, T. Kisseleva, D.A. Brenner, SREBP regulation of lipid metabolism in liver disease, and therapeutic strategies. Biomedicines 11, 3280 (2023)","journal-title":"Biomedicines"},{"key":"4561_CR129","first-page":"377","volume":"16","author":"MC Petersen","year":"2020","unstructured":"M.C. Petersen, V.T. Samuel, K.F. Petersen, G.I. Shulman, Non-alcoholic fatty liver disease and insulin resistance. Nat. Rev. Endocrinol. 16, 377\u2013390 (2020)","journal-title":"Nat. Rev. Endocrinol."},{"key":"4561_CR130","doi-asserted-by":"publisher","first-page":"134","DOI":"10.3389\/fendo.2015.00134","volume":"6","author":"S Hammerstad","year":"2015","unstructured":"S. Hammerstad, S. Grock, H. Lee, A. Hasham, N. Sundaram, Y. Tomer, Diabetes and hepatitis C: A two-way association. Front. Endocrinol. 6, 134 (2015)","journal-title":"Front. Endocrinol."},{"key":"4561_CR131","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s00011-017-1029-3","volume":"66","author":"R Nawaz","year":"2017","unstructured":"R. Nawaz, S. Zahid, M. Idrees, M. Rafique, S. Shahid, M. Ahmad, HCV-induced regulatory alterations of IL-1\u03b2, IL-6, TNF-\u03b1, and IFN-\u03b3 operative, leading liver en-route to non-alcoholic steatohepatitis. Inflamm. Res. 66, 477\u2013486 (2017)","journal-title":"Inflamm. Res."},{"key":"4561_CR132","first-page":"11783","volume":"20","author":"H Ahmadieh","year":"2014","unstructured":"H. Ahmadieh, S. Azar, Liver disease and diabetes: Association, pathophysiology, and management. World J. Gastroenterol. 20, 11783\u201311799 (2014)","journal-title":"World J. Gastroenterol."},{"key":"4561_CR133","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.3748\/wjg.v23.i9.1697","volume":"23","author":"A Desbois","year":"2017","unstructured":"A. Desbois, P. Cacoub, Diabetes mellitus, insulin resistance and hepatitis C virus infection: A contemporary review. World J. Gastroenterol. 23, 1697\u20131711 (2017)","journal-title":"World J. Gastroenterol."},{"key":"4561_CR134","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1126\/science.271.5249.665","volume":"271","author":"GS Hotamisligil","year":"1996","unstructured":"G.S. Hotamisligil, P. Peraldi, A. Budavari, R. Ellis, M.F. White, B.M. Spiegelman, IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-\u03b1- and obesity-induced insulin resistance. Science 271, 665\u2013668 (1996)","journal-title":"Science"},{"key":"4561_CR135","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1111\/jgh.12700","volume":"30","author":"CC Wang","year":"2015","unstructured":"C.C. Wang, C.S. Hsu, C.J. Liu, J.H. Kao, D.S. Chen, Hepatitis B virus infection and metabolic syndrome: Fact or fiction? J. Gastroenterol. Hepatol. 30, 14\u201320 (2015)","journal-title":"J. Gastroenterol. Hepatol."},{"key":"4561_CR136","doi-asserted-by":"publisher","first-page":"965548","DOI":"10.3389\/fimmu.2022.965548","volume":"13","author":"E Tourkochristou","year":"2022","unstructured":"E. Tourkochristou, S.F. Assimakopoulos, K. Thomopoulos, M. Marangos, C. Triantos, NAFLD and HBV interplay \u2013 related mechanisms underlying liver disease progression. Front. Immunol. 13, 965548 (2022)","journal-title":"Front. Immunol."},{"key":"4561_CR137","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1111\/hepr.12481","volume":"45","author":"J Zhang","year":"2015","unstructured":"J. Zhang, Y. Shen, H. Cai, Y.M. Liu, G. Qin, Hepatitis B virus infection status and risk of type 2 diabetes mellitus: A meta-analysis. Hepatol. Res. 45, 1100\u20131109 (2015)","journal-title":"Hepatol. Res."},{"key":"4561_CR138","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s11154-017-9440-1","volume":"19","author":"S Fabiani","year":"2018","unstructured":"S. Fabiani, P. Fallahi, S. Ferrari, M. Miccoli, A. Antonelli, Hepatitis C virus infection and development of type 2 diabetes mellitus: Systematic review and meta-analysis of the literature. Rev. Endocr. Metab. Disord. 19, 405\u2013420 (2018)","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"4561_CR139","first-page":"141","volume":"43","author":"M Fujii","year":"2013","unstructured":"M. Fujii, Y. Shibazaki, K. Wakamatsu, Y. Honda, Y. Kawauchi, K. Suzuki, S. Arumugam, K. Watanabe, T. Ichida, H. Asakura, H. Yoneyama, A murine model for non-alcoholic steatohepatitis showing evidence of association between diabetes and hepatocellular carcinoma. Hepatol. Res. 43, 141\u2013152 (2013)","journal-title":"Hepatol. Res."},{"key":"4561_CR140","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1002\/hep.23594","volume":"51","author":"BQ Starley","year":"2010","unstructured":"B.Q. Starley, C.J. Calcagno, S.A. Harrison, Nonalcoholic fatty liver disease and hepatocellular carcinoma: A weighty connection. Hepatology 51, 1820\u20131832 (2010)","journal-title":"Hepatology"},{"key":"4561_CR141","doi-asserted-by":"publisher","first-page":"6434","DOI":"10.3390\/ijms22126434","volume":"22","author":"A Kasprzak","year":"2021","unstructured":"A. Kasprzak, Insulin-like growth factor 1 (IGF-1) signaling in glucose metabolism in colorectal cancer. Int. J. Mol. Sci. 22, 6434 (2021)","journal-title":"Int. J. Mol. Sci."},{"key":"4561_CR142","doi-asserted-by":"publisher","first-page":"10260","DOI":"10.3390\/ijms221910260","volume":"22","author":"C Stefani","year":"2021","unstructured":"C. Stefani, D. Miricescu, I.I. Stanescu-Spinu, R.I. Nica, M. Greabu, A.R. Totan, M. Jinga, Growth factors, PI3K\/AKT\/mTOR and MAPK signaling pathways in colorectal cancer pathogenesis: where are we now? Int. J. Mol. Sci. 22, 10260 (2021)","journal-title":"Int. J. Mol. Sci."},{"key":"4561_CR143","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","volume":"397","author":"EE Powell","year":"2021","unstructured":"E.E. Powell, V.W. Wong, M. Rinella, Non-alcoholic fatty liver disease. Lancet 397, 2212\u20132224 (2021)","journal-title":"Lancet"},{"key":"4561_CR144","first-page":"829","volume":"88","author":"C Postic","year":"2008","unstructured":"C. Postic, J. Girard, Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: Lessons from genetically engineered mice. Physiol. Rev. 88, 829\u2013838 (2008)","journal-title":"Physiol. Rev."},{"key":"4561_CR145","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.cell.2009.12.052","volume":"140","author":"EJ Park","year":"2010","unstructured":"E.J. Park, J.H. Lee, G.Y. Yu, G. He, S.R. Ali, R.G. Holzer, C.H. Osterreicher, H. Takahashi, M. Karin, Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression. Cell 140, 197\u2013208 (2010)","journal-title":"Cell"},{"key":"4561_CR146","doi-asserted-by":"publisher","first-page":"286","DOI":"10.31083\/j.fbl2811286","volume":"28","author":"Y Li","year":"2023","unstructured":"Y. Li, Y. Yu, L. Yang, R. Wang, Insights into the role of oxidative stress in hepatocellular carcinoma development. Front. Biosci. 28, 286 (2023)","journal-title":"Front. Biosci."},{"key":"4561_CR147","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1053\/j.gastro.2019.11.311","volume":"158","author":"RF Schwabe","year":"2020","unstructured":"R.F. Schwabe, T.F. Greten, Gut microbiome in HCC: Mechanisms, diagnosis, and therapy. Gastroenterology 158, 513\u2013528 (2020)","journal-title":"Gastroenterology"},{"key":"4561_CR148","doi-asserted-by":"publisher","first-page":"100157","DOI":"10.1016\/j.medmic.2025.100157","volume":"26","author":"P Manothiya","year":"2025","unstructured":"P. Manothiya, D. Dash, R.K. Koiri, Gut microbiota dysbiosis and the gut\u2013liver\u2013brain axis: Mechanistic insights into hepatic encephalopathy. Med. Microecol. 26, 100157 (2025)","journal-title":"Med. Microecol."},{"key":"4561_CR149","doi-asserted-by":"publisher","first-page":"1145392","DOI":"10.3389\/fendo.2023.1145392","volume":"14","author":"C Huang","year":"2023","unstructured":"C. Huang, Y. Zhou, J. Cheng, X. Guo, D. Shou, Y. Quan, H. Chen, H. Chen, Y. Zhou, Pattern recognition receptors in the development of nonalcoholic fatty liver disease and progression to hepatocellular carcinoma: an emerging therapeutic strategy. Front. Endocrinol. 14, 1145392 (2023)","journal-title":"Front. Endocrinol."},{"key":"4561_CR150","first-page":"2449","volume":"56","author":"S Schlesinger","year":"2013","unstructured":"S. Schlesinger, K. Aleksandrova, T. Pischon, V. Fedirko, M. Jenab, E. Tr\u00e9po, P. Boffetta, C.C. Dahm, K. Overvad, A. Tj\u00f8nneland, J. Halkj\u00e6r, M.C. Boutron-Ruault, G. Fagherazzi, A. Racine, H. Boeing, A. Trichopoulou, C. La Vecchia, C. Bamia, D. Palli, V. Pala, R. Tumino, C. Sacerdote, S. Panico, H.B. Bueno-de-Mesquita, P.D. Siersema, P.H. Peeters, E. Weiderpass, G. Skeie, D. Engeset, J.R. Quir\u00f3s, A. Agudo, M.J. Sanchez, N. Larra\u00f1aga, C. Navarro, I. Barricarte, T.J. Key, K.T. Khaw, N. Wareham, S. Rinaldi, A.J. Cross, M.J. Gunter, M.F. Leitzmann, Diabetes mellitus, insulin treatment, diabetes duration, and risk of biliary tract cancer and hepatocellular carcinoma in a European cohort. Diabetologia 56, 2449\u20132455 (2013)","journal-title":"Diabetologia"},{"key":"4561_CR151","doi-asserted-by":"publisher","first-page":"468","DOI":"10.3390\/biomedicines11020468","volume":"11","author":"E Vetrano","year":"2023","unstructured":"E. Vetrano, F. Rossi, L. Bianchi, M. Romano, A. Conti, G. Esposito, P. Russo, Non-alcoholic fatty liver disease (NAFLD), type 2 diabetes, and non-viral hepatocarcinoma: Pathophysiological mechanisms and new therapeutic strategies. Biomedicines 11, 468 (2023)","journal-title":"Biomedicines"},{"key":"4561_CR152","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1038\/ajg.2013.5","volume":"108","author":"S Singh","year":"2013","unstructured":"S. Singh, P.P. Singh, A.G. Singh, M.H. Murad, R.R. McWilliams, W. Sanchez, S. Singh, Anti-diabetic medications and the risk of hepatocellular cancer: A systematic review and meta-analysis. Am. J. Gastroenterol. 108, 881\u2013891 (2013)","journal-title":"Am. J. Gastroenterol."},{"key":"4561_CR153","first-page":"100184","volume":"5","author":"D Dash","year":"2025","unstructured":"D. Dash, P. Kesharwani, R.K. Koiri, Comprehensive approach to liver cirrhosis treatment: Integrating Ayurveda, Homeopathy, and Allopathy. Pharmacol. Res. Nat. Prod. 5, 100184 (2025)","journal-title":"Pharmacol. Res. Nat. Prod."},{"key":"4561_CR154","first-page":"100031","volume":"6","author":"K Pandey","year":"2024","unstructured":"K. Pandey, D. Dash, R.K. Koiri, Liver lobes and cirrhosis: Diagnostic insights from lobar ratios. Gastroenterol. Endosc. 6, 100031 (2024)","journal-title":"Gastroenterol. Endosc."},{"key":"4561_CR155","doi-asserted-by":"publisher","first-page":"112008","DOI":"10.1016\/j.diabres.2025.112008","volume":"220","author":"S Yin","year":"2025","unstructured":"S. Yin, F. Zhu, Y. Liu, Q. Chen, Effects of silymarin on insulin resistance and sensitivity: A systematic review and meta-analysis of randomized controlled trials. Diabetes Res. Clin. Pract. 220, 112008 (2025)","journal-title":"Diabetes Res. Clin. Pract."},{"key":"4561_CR156","doi-asserted-by":"publisher","first-page":"16354","DOI":"10.3390\/ijms242216354","volume":"24","author":"S Roy","year":"2023","unstructured":"S. Roy, P. Saha, D. Bose, A. Trivedi, M. More, S. Xiao, A.M. Diehl, S. Chatterjee, Hepatic NLRP3-derived Hsp70 binding to TLR4 mediates MASLD to MASH progression upon inhibition of PP2A by harmful algal bloom toxin microcystin, a second hit. Int. J. Mol. Sci. 24, 16354 (2023)","journal-title":"Int. J. Mol. Sci."},{"key":"4561_CR157","first-page":"806","volume":"6","author":"D Garc\u00eda-Compe\u00e1n","year":"2015","unstructured":"D. Garc\u00eda-Compe\u00e1n, J.A. Gonz\u00e1lez-Gonz\u00e1lez, F.J. Lavalle-Gonz\u00e1lez, E.I. Gonz\u00e1lez-Moreno, J.Z. Villarreal-P\u00e9rez, H.J. Maldonado-Garza, Hepatogenous diabetes: current concepts and treatment. World J. Diabetes 6, 806\u2013813 (2015)","journal-title":"World J. Diabetes"},{"key":"4561_CR158","doi-asserted-by":"publisher","first-page":"262","DOI":"10.3390\/jcm10020262","volume":"10","author":"LI Coman","year":"2021","unstructured":"L.I. Coman, O.A. Coman, I.A. B\u0103d\u0103r\u0103u, H. P\u0103unescu, M. Cioc\u00eerlan, Association between liver cirrhosis and diabetes mellitus: a review on hepatic outcomes. J. Clin. Med. 10, 262 (2021)","journal-title":"J. Clin. Med."},{"key":"4561_CR159","doi-asserted-by":"publisher","first-page":"58","DOI":"10.3390\/diseases7040058","volume":"7","author":"H Fukui","year":"2019","unstructured":"H. Fukui, Role of gut dysbiosis in liver diseases: what have we learned so far? Diseases 7, 58 (2019)","journal-title":"Diseases"},{"key":"4561_CR160","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.4254\/wjh.v14.i7.1291","volume":"14","author":"R Kumar","year":"2022","unstructured":"R. Kumar, D. Garc\u00eda-Compe\u00e1n, T. Maji, Hepatogenous diabetes: knowledge, evidence, and skepticism. World J. Hepatol. 14, 1291\u20131306 (2022)","journal-title":"World J. Hepatol."},{"key":"4561_CR161","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/S2468-1253(21)00308-3","volume":"6","author":"A Mantovani","year":"2021","unstructured":"A. Mantovani, A. Csermely, G. Petracca, G. Beatrice, K.E. Corey, T.G. Simon, C.D. Byrne, G. Targher, Non-alcoholic fatty liver disease and risk of fatal and non-fatal cardiovascular events: an updated systematic review and meta-analysis. Lancet Gastroenterol. Hepatol. 6, 903\u2013913 (2021)","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"4561_CR162","doi-asserted-by":"publisher","first-page":"775","DOI":"10.3748\/wjg.v28.i8.775","volume":"28","author":"D Garc\u00eda-Compe\u00e1n","year":"2022","unstructured":"D. Garc\u00eda-Compe\u00e1n, E. Orsi, R. Kumar, F. Gundling, T. Nishida, J.Z. Villarreal-P\u00e9rez, \u00c1.N. Del Cueto-Aguilera, J.A. Gonz\u00e1lez-Gonz\u00e1lez, G. Pugliese, Clinical implications of diabetes in chronic liver disease: diagnosis, outcomes and management, current and future perspectives. World J. Gastroenterol. 28, 775\u2013793 (2022)","journal-title":"World J. Gastroenterol."},{"key":"4561_CR163","first-page":"11234","volume":"58","author":"Y Shu","year":"2024","unstructured":"Y. Shu, H. Jiang, X. Gao, P. Hong, Q. Wang, Y. Ruan, H. Wu, J. He, Microcystin-LR induces lipid metabolism disorder in Pelophylax nigromaculatus tadpoles via the gut\u2013liver axis. Env. Sci. Technol. 58, 11234\u201311243 (2024)","journal-title":"Env. Sci. Technol."},{"key":"4561_CR164","doi-asserted-by":"publisher","first-page":"204201882110324","DOI":"10.1177\/20420188211055557","volume":"12","author":"J Mertens","year":"2021","unstructured":"J. Mertens, L.F. Van Gaal, S.M. Francque, C. De Block, NAFLD in type 1 diabetes: Overrated or underappreciated? Ther. Adv. Endocrinol. Metab. 12, 20420188211032454 (2021)","journal-title":"Ther. Adv. Endocrinol. Metab."},{"key":"4561_CR165","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","volume":"79","author":"ME Rinella","year":"2023","unstructured":"M.E. Rinella, J.V. Lazarus, V. Ratziu, S.M. Francque, A.J. Sanyal, F. Kanwal, M. Romero-G\u00f3mez, M. Arrese, A.S. Barritt, S. Bellentani, E. Bugianesi, N.P. Chalasani, H. Cortez-Pinto, K. Cusi, V. de L\u00e9dinghen, H.B. El-Serag, J.G. Fan, S. Fargion, G.C. Farrell, J. George, H. Hagstr\u00f6m, V.A. Isakov, J. Itakura, S.U. Kim, D.E. Kleiner, J. Kozlitina, M. Kumar, K.N. Lazaridis, H.W. Lee, R. Loomba, A. Louvet, M.V. Machado, T. Marjot, A. Nakajima, P.N. Newsome, G.V. Papatheodoridis, D. Romero, J.M. Schattenberg, S. Sethasine, G. Shiha, C.W. Spearman, Y. Sumida, J.H. Tabibian, Y. Tanaka, H. Tilg, M. Trauner, E.A. Tsochatzis, L. Valenti, V.W. Wong, G.L. Wong, Z.M. Younossi, Y. Yilmaz, A multi-society Delphi consensus statement on new fatty liver disease nomenclature. J. Hepatol. 79, 1542\u20131556 (2023)","journal-title":"J. Hepatol."},{"key":"4561_CR166","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.jhep.2019.06.021","volume":"71","author":"ZM Younossi","year":"2018","unstructured":"Z.M. Younossi, P. Golabi, L. de Avila, J.M. Paik, M. Srishord, N. Fukui, Y. Qiu, L. Burns, A. Afendy, F. Nader, The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: A systematic review and meta-analysis. J. Hepatol. 71, 793\u2013801 (2018)","journal-title":"J. Hepatol."},{"key":"4561_CR167","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.jhep.2005.06.018","volume":"44","author":"A Lonardo","year":"2005","unstructured":"A. Lonardo, S. Lombardini, F. Scaglioni, L. Carulli, M. Ricchi, D. Ganazzi, L.E. Adinolfi, G. Ruggiero, N. Carulli, P. Loria, Hepatic steatosis and insulin resistance: Does etiology make a difference? J. Hepatol. 44, 190\u2013196 (2005)","journal-title":"J. Hepatol."},{"key":"4561_CR168","first-page":"273","volume":"31","author":"FR Jornayvaz","year":"2011","unstructured":"F.R. Jornayvaz, V.T. Samuel, G.I. Shulman, The role of muscle insulin resistance in the pathogenesis of atherogenic dyslipidemia and non-alcoholic fatty liver disease associated with the metabolic syndrome. Annu. Rev. Nutr. 31, 273\u2013290 (2011)","journal-title":"Annu. Rev. Nutr."},{"key":"4561_CR169","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.7150\/ijbs.47143","volume":"16","author":"J Chen","year":"2020","unstructured":"J. Chen, X. Deng, Y. Liu, Q. Tan, G. Huang, Q. Che, J. Guo, Z. Su, Kupffer cells in non-alcoholic fatty liver disease: friend or foe? Int. J. Biol. Sci. 16, 2367\u20132378 (2020)","journal-title":"Int. J. Biol. Sci."},{"key":"4561_CR170","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.3390\/cells10051004","volume":"10","author":"S Kiran","year":"2021","unstructured":"S. Kiran, V. Kumar, S. Kumar, R.L. Price, U.P. Singh, Adipocyte, immune cells, and miRNA crosstalk: a novel regulator of metabolic dysfunction and obesity. Cells 10, 1004 (2021)","journal-title":"Cells"},{"key":"4561_CR171","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-025-10455-y","volume":"25","author":"J Wei","year":"2025","unstructured":"J. Wei, W. Hui, Y. Fang, H. Jia, Y. Yang, T. Zhang, H. Wu, B. Su, T. Jiang, The prevalence of nonalcoholic fatty liver disease in people living with HIV: a systematic review and meta-analysis. BMC Infect. Dis. 25, 239 (2025)","journal-title":"BMC Infect. Dis."},{"key":"4561_CR172","first-page":"34","volume":"1524","author":"W Fan","year":"2024","unstructured":"W. Fan, T. Bradford, N. T\u00f6r\u00f6k, Metabolic dysfunction-associated liver disease and diabetes: matrix remodeling, fibrosis, and therapeutic implications. Ann. N. Y. Acad. Sci. 1524, 34\u201348 (2024)","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"4561_CR173","doi-asserted-by":"publisher","first-page":"S135","DOI":"10.1055\/s-2001-18576","volume":"109","author":"HE Lebovitz","year":"2001","unstructured":"H.E. Lebovitz, Insulin resistance: definition and consequences. Exp. Clin. Endocrinol. Diabetes 109, S135\u2013S148 (2001)","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"4561_CR174","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1186\/s12944-017-0572-9","volume":"16","author":"Z Chen","year":"2017","unstructured":"Z. Chen, R. Yu, Y. Xiong, F. Du, S. Zhu, A vicious circle between insulin resistance and inflammation in nonalcoholic fatty liver disease. Lipids Health Dis. 16, 203 (2017)","journal-title":"Lipids Health Dis."},{"key":"4561_CR175","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1136\/gutjnl-2012-303816","volume":"62","author":"T Le Roy","year":"2013","unstructured":"T. Le Roy, M. Llopis, P. Lepage, A. Bruneau, S. Rabot, C. Bevilacqua, P. Martin, C. Philippe, F. Walker, A. Bado, G. Perlemuter, A.M. Cassard-Doulcier, P. G\u00e9rard, Intestinal microbiota determines development of non-alcoholic fatty liver disease in mice. Gut 62, 1787\u20131794 (2013)","journal-title":"Gut"},{"key":"4561_CR176","doi-asserted-by":"publisher","first-page":"61","DOI":"10.3390\/jpm14010061","volume":"14","author":"H Ali","year":"2024","unstructured":"H. Ali, M. Shahzil, V. Moond, M. Shahzad, A. Thandavaram, A. Sehar, H. Waseem, T. Siddiqui, D.S. Dahiya, P. Patel, H. Tillmann, Non-pharmacological approach to diet and exercise in metabolic-associated fatty liver disease: bridging the gap between research and clinical practice. J. Pers. Med. 14, 61 (2024)","journal-title":"J. Pers. Med."},{"key":"4561_CR177","doi-asserted-by":"publisher","first-page":"1149239","DOI":"10.3389\/fendo.2023.1149239","volume":"14","author":"X Zhao","year":"2023","unstructured":"X. Zhao, X. An, C. Yang et al. The crucial role and mechanism of insulin resistance in metabolic disease. Front. Endocrinol. 14, 1149239 (2023)","journal-title":"Front. Endocrinol."},{"key":"4561_CR178","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s11739-023-03374-w","volume":"19","author":"F Di Vincenzo","year":"2024","unstructured":"F. Di Vincenzo, A. Del Gaudio, V. Petito et al. Gut microbiota, intestinal permeability, and systemic inflammation: a narrative review. Intern. Emerg. Med. 19, 275\u2013293 (2024)","journal-title":"Intern. Emerg. Med."},{"key":"4561_CR179","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1136\/gutjnl-2023-330110","volume":"72","author":"EE Li Cho","year":"2023","unstructured":"E.E. Li Cho, C.Z. Ang, J. Quek, D.J. Tan, P. Tay, M. Teng, W.H. Lim, Y.Y. Dan, L. Tan, B. Tan, M.D. Muthiah, J.N. Yong, J. Fung, J.G. Fan, H. Toyoda, K. Imajo, L. Kikuchi, W.K. Chan, G.B. Goh, S.G. Lim, Global prevalence of non-alcoholic fatty liver disease in type 2 diabetes mellitus: An updated systematic review and meta-analysis. Gut 72, 2138\u20132148 (2023)","journal-title":"Gut"},{"key":"4561_CR180","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1080\/17474124.2024.2388790","volume":"18","author":"ML Yeh","year":"2024","unstructured":"M.L. Yeh, J.F. Huang, C.Y. Dai, C.F. Huang, M.L. Yu, W.L. Chuang, Metabolic dysfunction-associated steatotic liver disease and diabetes: The cross-talk between hepatologist and diabetologist. Expert. Rev. Gastroenterol. Hepatol. 18, 431\u2013439 (2024)","journal-title":"Expert. Rev. Gastroenterol. Hepatol."},{"key":"4561_CR181","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11739-025-03902-w","volume":"20","author":"MA Amin","year":"2025","unstructured":"M.A. Amin, N.A. Sadik, H.A. Saad, M. Fawzy, H.A. Elsheimy, The effect of SGLT2 inhibitors on hepatic steatosis detected by MRI-PDFF in patients with type 2 diabetes mellitus and metabolic-associated steatotic liver disease. Intern. Emerg. Med. 20, 1\u201310 (2025)","journal-title":"Intern. Emerg. Med."},{"key":"4561_CR182","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.jhepr.2019.07.002","volume":"1","author":"A Gastaldelli","year":"2019","unstructured":"A. Gastaldelli, K. Cusi, From NASH to diabetes and from diabetes to NASH: Mechanisms and treatment options. JHEP Rep. 1, 312\u2013328 (2019)","journal-title":"JHEP Rep."},{"key":"4561_CR183","doi-asserted-by":"publisher","first-page":"14205","DOI":"10.3748\/wjg.v20.i39.14205","volume":"20","author":"G Paradies","year":"2014","unstructured":"G. Paradies, V. Paradies, F.M. Ruggiero, G. Petrosillo, Oxidative stress, cardiolipin and mitochondrial dysfunction in nonalcoholic fatty liver disease. World J. Gastroenterol. 20, 14205\u201314218 (2014)","journal-title":"World J. Gastroenterol."},{"key":"4561_CR184","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1053\/j.gastro.2012.06.004","volume":"143","author":"E Seki","year":"2012","unstructured":"E. Seki, D.A. Brenner, M. Karin, A liver full of JNK: Signaling in regulation of cell function and disease pathogenesis, and clinical approaches. Gastroenterology 143, 307\u2013320 (2012)","journal-title":"Gastroenterology"},{"key":"4561_CR185","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1152\/physrev.00013.2007","volume":"88","author":"SL Friedman","year":"2008","unstructured":"S.L. Friedman, Hepatic stellate cells: Protean, multifunctional, and enigmatic cells of the liver. Physiol. Rev. 88, 125\u2013172 (2008)","journal-title":"Physiol. Rev."},{"key":"4561_CR186","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.mam.2018.09.002","volume":"65","author":"M Parola","year":"2019","unstructured":"M. Parola, M. Pinzani, Liver fibrosis: Pathophysiology, pathogenetic targets, and clinical issues. Mol. Asp. Med. 65, 37\u201355 (2019)","journal-title":"Mol. Asp. Med."},{"key":"4561_CR187","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1038\/ki.2010.516","volume":"79","author":"JL Barnes","year":"2011","unstructured":"J.L. Barnes, Y. Gorin, Myofibroblast differentiation during fibrosis: Role of NADPH oxidases. Kidney Int. 79, 944\u2013956 (2011)","journal-title":"Kidney Int."},{"key":"4561_CR188","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1002\/hep.24001","volume":"52","author":"H Tilg","year":"2010","unstructured":"H. Tilg, A.R. Moschen, Evolution of inflammation in nonalcoholic fatty liver disease: The multiple parallel hits hypothesis. Hepatology 52, 1836\u20131848 (2010)","journal-title":"Hepatology"},{"key":"4561_CR189","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3748\/wjg.v25.i21.2549","volume":"25","author":"D Garc\u00eda-Compe\u00e1n","year":"2019","unstructured":"D. Garc\u00eda-Compe\u00e1n, J.A. Gonz\u00e1lez-Gonz\u00e1lez, F.J. Lavalle-Gonz\u00e1lez, E.I. Gonz\u00e1lez-Moreno, J.Z. Villarreal-P\u00e9rez, H.J. Maldonado-Garza, Liver cirrhosis and diabetes: Risk factors, pathophysiology, and clinical implications. World J. Gastroenterol. 25, 36\u201348 (2019)","journal-title":"World J. Gastroenterol."},{"key":"4561_CR190","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4196\/kjpp.2014.18.1.1","volume":"18","author":"VP Singh","year":"2014","unstructured":"V.P. Singh, A. Bali, N. Singh, A.S. Jaggi, Advanced glycation end products and diabetic complications. Korean J. Physiol. Pharmacol. 18, 1\u201314 (2014)","journal-title":"Korean J. Physiol. Pharmacol."},{"key":"4561_CR191","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1089\/rej.2012.1335","volume":"15","author":"S Yamagishi","year":"2012","unstructured":"S. Yamagishi, T. Matsui, K. Fukami, Role of receptor for advanced glycation end products (RAGE) and its ligands in cancer risk. Rejuvenation Res. 15, 211\u2013216 (2012)","journal-title":"Rejuvenation Res."},{"key":"4561_CR192","doi-asserted-by":"publisher","first-page":"113888","DOI":"10.1016\/j.addr.2021.113888","volume":"176","author":"V Kumar","year":"2021","unstructured":"V. Kumar, X. Xin, J. Ma, C. Tan, N. Osna, R.I. Mahato, Therapeutic targets, novel drugs, and delivery systems for diabetes associated NAFLD and liver fibrosis. Adv. Drug. Deliv. Rev. 176, 113888 (2021)","journal-title":"Adv. Drug. Deliv. Rev."},{"key":"4561_CR193","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1053\/j.gastro.2015.04.005","volume":"149","author":"E Vilar-Gomez","year":"2015","unstructured":"E. Vilar-Gomez, Y. Martinez-Perez, L. Calzadilla-Bertot, A. Torres-Gonzalez, B. Gra-Oramas, L. Gonzalez-Fabian, S.L. Friedman, M. Diago, M. Romero-Gomez, L.A. Adams, Weight loss through lifestyle modification significantly reduces features of nonalcoholic steatohepatitis. Gastroenterology 149, 367\u2013378 (2015)","journal-title":"Gastroenterology"},{"key":"4561_CR194","doi-asserted-by":"publisher","first-page":"82","DOI":"10.2337\/diaspect.27.2.82","volume":"27","author":"JR White","year":"2014","unstructured":"J.R. White, Jr., A brief history of the development of diabetes medications. Diabetes Spectr. 27, 82\u201386 (2014)","journal-title":"Diabetes Spectr."},{"key":"4561_CR195","first-page":"716","volume":"17","author":"G Goodkin","year":"1975","unstructured":"G. Goodkin, Mortality factors in diabetes: A 20-year mortality study. J. Occup. Med. 17, 716\u2013721 (1975)","journal-title":"J. Occup. Med."},{"key":"4561_CR196","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1016\/S0140-6736(14)60121-5","volume":"383","author":"EA Tsochatzis","year":"2014","unstructured":"E.A. Tsochatzis, J. Bosch, A.K. Burroughs, Liver cirrhosis. Lancet 383, 1749\u20131761 (2014)","journal-title":"Lancet"},{"key":"4561_CR197","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.2040-1124.2012.00237.x","volume":"4","author":"JF Huang","year":"2013","unstructured":"J.F. Huang, C.Y. Dai, M.L. Yu, W.L. Chuang, C.F. Huang, M.L. Yeh, Z.Y. Lin, S.C. Chen, M.Y. Hsieh, L.Y. Wang, L.P. Lee, W.Y. Chang, S.M. Lin, P.J. Chen, J.H. Kao, Hepatitis C virus infection and risk of type 2 diabetes mellitus: A systematic review and meta-analysis. J. Diabetes Investig. 4, 133\u2013142 (2013)","journal-title":"J. Diabetes Investig."},{"key":"4561_CR198","doi-asserted-by":"publisher","first-page":"792","DOI":"10.3390\/nu15030792","volume":"15","author":"ML Petroni","year":"2023","unstructured":"M.L. Petroni, L. Brodosi, A. Armandi, F. Marchignoli, E. Bugianesi, G. Marchesini, Lifestyle intervention in NAFLD: Long-term diabetes incidence in subjects treated by web- and group-based programs. Nutrients 15, 792 (2023)","journal-title":"Nutrients"},{"key":"4561_CR199","doi-asserted-by":"publisher","first-page":"66202","DOI":"10.18632\/oncotarget.11033","volume":"7","author":"SJ Ma","year":"2016","unstructured":"S.J. Ma, Y.X. Zheng, P.C. Zhou, Y.N. Xiao, H.Z. Tan, Metformin use improves survival of diabetic liver cancer patients: Systematic review and meta-analysis. Oncotarget 7, 66202\u201366211 (2016)","journal-title":"Oncotarget"},{"key":"4561_CR200","doi-asserted-by":"publisher","first-page":"78","DOI":"10.3390\/biomedicines13010078","volume":"13","author":"Y Hirata","year":"2024","unstructured":"Y. Hirata, Y. Sakuma, H. Ogiso, R. Nagai, K. Aizawa, Targeted plasma bile acid metabolomic analysis in metabolic dysfunction-associated steatohepatitis and alcoholic hepatitis. Biomedicines 13, 78 (2024)","journal-title":"Biomedicines"},{"key":"4561_CR201","doi-asserted-by":"publisher","first-page":"101436","DOI":"10.3748\/wjg.v31.i4.101436","volume":"31","author":"A Cort\u00e9s-Mart\u00edn","year":"2025","unstructured":"A. Cort\u00e9s-Mart\u00edn, J. Plaza-Diaz, Exploring the therapeutic potential of glucagon-like peptide 1 agonists in metabolic disorders. World J. Gastroenterol. 31, 101436 (2025)","journal-title":"World J. Gastroenterol."},{"key":"4561_CR202","first-page":"1","volume":"398","author":"MA Aghajani Bac","year":"2025","unstructured":"M.A. Aghajani Bac, Z. Nasehi, F. Zadhoush, The beneficial effects of empagliflozin\u2013metformin combination on cardiovascular risk factors in type 2 diabetes mellitus patients. Naunyn Schmiedebergs Arch. Pharmacol. 398, 1\u201310 (2025)","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"4561_CR203","doi-asserted-by":"publisher","first-page":"571731","DOI":"10.3389\/fimmu.2020.571731","volume":"11","author":"TPM Scheithauer","year":"2020","unstructured":"T.P.M. Scheithauer, E. Rampanelli, M. Nieuwdorp, B.A. Vallance, C.B. Verchere, D.H. van Raalte, H. Herrema, Gut microbiota as a trigger for metabolic inflammation in obesity and type 2 diabetes. Front. Immunol. 11, 571731 (2020)","journal-title":"Front. Immunol."},{"key":"4561_CR204","doi-asserted-by":"publisher","first-page":"109090","DOI":"10.3748\/wjg.v31.i29.109090","volume":"31","author":"MMI Abdalla","year":"2025","unstructured":"M.M.I. Abdalla, Gut\u2013liver axis in diabetes: Mechanisms and therapeutic opportunities. World J. Gastroenterol. 31, 109090 (2025)","journal-title":"World J. Gastroenterol."},{"key":"4561_CR205","doi-asserted-by":"publisher","first-page":"1661155","DOI":"10.3389\/fcimb.2025.1661155","volume":"15","author":"C Wang","year":"2025","unstructured":"C. Wang, M. Yu, Y. Che, R. Du, Y. Xu, J. Niu, X. Chi, Advance in molecular mechanisms underlying diabetes related to viral hepatitis infection. Front. Cell Infect. Microbiol. 15, 1661155 (2025)","journal-title":"Front. Cell Infect. Microbiol."},{"key":"4561_CR206","doi-asserted-by":"publisher","first-page":"24","DOI":"10.5009\/gnl220357","volume":"17","author":"PC Teng","year":"2023","unstructured":"P.C. Teng, D.Q. Huang, T.Y. Lin, M. Noureddin, J.D. Yang, Diabetes and risk of hepatocellular carcinoma in cirrhosis patients with nonalcoholic fatty liver disease. Gut Liver 17, 24\u201333 (2023)","journal-title":"Gut Liver"},{"key":"4561_CR207","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.2337\/dci24-0094","volume":"48","author":"K Cusi","year":"2025","unstructured":"K. Cusi, M.F. Abdelmalek, C.M. Apovian, K. Balapattabi, R.R. Bannuru, D. Barb, J.K. Bardsley, E.A. Beverly, K.D. Corbin, N.A. ElSayed, S. Isaacs, F. Kanwal, E.J. Pekas, C.R. Richardson, M. Roden, A.J. Sanyal, J.H. Shubrook, Z.M. Younossi, M. Bajaj, Metabolic dysfunction-associated steatotic liver disease (MASLD) in people with diabetes: The need for screening and early intervention\u2014A consensus report of the American Diabetes Association. Diabetes Care 48, 1057\u20131082 (2025)","journal-title":"Diabetes Care"},{"key":"4561_CR208","doi-asserted-by":"publisher","first-page":"92","DOI":"10.4103\/sjg.sjg_260_21","volume":"28","author":"J Chen","year":"2022","unstructured":"J. Chen, S. Song, X. Li, D. Bian, X. Wu, Association of metabolic traits with occurrence of nonalcoholic fatty liver disease\u2013related hepatocellular carcinoma: A systematic review and meta-analysis of longitudinal cohort studies. Saudi J. Gastroenterol. 28, 92\u2013100 (2022)","journal-title":"Saudi J. Gastroenterol."},{"key":"4561_CR209","doi-asserted-by":"publisher","first-page":"1669478","DOI":"10.3389\/fendo.2025.1669478","volume":"16","author":"MS Mohiuddin","year":"2025","unstructured":"M.S. Mohiuddin, N.T. Neha, J.U.K. Mahir, F.A.F. Shakib, M.A. Alam, M. Wahiduzzaman, R. Barua, S.J. Shimu, M. Rahman, M.R. Hossain, M.H. Shariare, M.M. Mohib, M.B. Uddin, Metabolic dysfunction-associated fatty liver disease and type 2 diabetes: Pathophysiological links, epidemiological trends, and clinical implications. Front Endocrinol (Lausanne) 16, 1669478 (2025)","journal-title":"Front Endocrinol (Lausanne)"},{"key":"4561_CR210","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1111\/apt.17997","volume":"59","author":"N Mittal","year":"2024","unstructured":"N. Mittal, H. Siddiqi, E. Madamba, L. Richards, R. Bettencourt, V. Ajmera, R. Loomba, A prospective study on the prevalence of at-risk MASH in patients with type 2 diabetes mellitus in the United States. Aliment. Pharmacol. Ther. 59, 1571\u20131578 (2024)","journal-title":"Aliment. Pharmacol. Ther."},{"key":"4561_CR211","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","volume":"73","author":"M Eslam","year":"2020","unstructured":"M. Eslam, P.N. Newsome, S.K. Sarin, Q.M. Anstee, G. Targher, M. Romero-Gomez, S. Zelber-Sagi, V.W. Wong, J.F. Dufour, J.M. Schattenberg, T. Kawaguchi, M. Arrese, L. Valenti, G. Shiha, C. Tiribelli, H. Yki-J\u00e4rvinen, J.G. Fan, H. Gr\u00f8nb\u00e6k, Y. Yilmaz, H. Cortez-Pinto, C.P. Oliveira, P. Bedossa, L.A. Adams, M.H. Zheng, Y. Fouad, W.K. Chan, N. Mendez-Sanchez, S.H. Ahn, L. Castera, E. Bugianesi, V. Ratziu, J. George, A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement. J. Hepatol. 73, 202\u2013209 (2020)","journal-title":"J. Hepatol."},{"key":"4561_CR212","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1007\/s00125-024-06196-3","volume":"67","author":"European Association for the Study of the Liver, European Association for the Study of Diabetes, European Association for the Study of Obesity","year":"2024","unstructured":"European Association for the Study of the Liver, European Association for the Study of Diabetes, European Association for the Study of Obesity, EASL-EASD-EASO clinical practice guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD): Executive summary. Diabetologia 67, 2375\u20132392 (2024)","journal-title":"Diabetologia"},{"key":"4561_CR213","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/s41575-020-00381-6","volume":"18","author":"DQ Huang","year":"2021","unstructured":"D.Q. Huang, H.B. El-Serag, R. Loomba, Global epidemiology of NAFLD-related hepatocellular carcinoma: Trends, predictions, risk factors and prevention. Nat. Rev. Gastroenterol. Hepatol. 18, 223\u2013238 (2021)","journal-title":"Nat. Rev. Gastroenterol. Hepatol."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-026-04561-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-026-04561-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-026-04561-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T19:03:42Z","timestamp":1771268622000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-026-04561-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,16]]},"references-count":213,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4561"],"URL":"https:\/\/doi.org\/10.1007\/s12020-026-04561-3","relation":{},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,16]]},"assertion":[{"value":"23 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"74"}}